BioPharma
20 March, 2026 | Friday | News
SK Pharmteco Commits 100 Million Dollars To Strengthen Viral Vector Capabilities And Multi Modality CDMO Strategy
SK pharmteco announced a significant funding commitment to support strategic initiatives within its viral vector business, while reaffirming its long-term growth strategy across three business units: small mole...
Lab
20 March, 2026 | Friday | News
Pace Life Sciences Advances Digital Laboratory Operations With Labguru Platform Integration
Cenevo’s Labguru platform is delivering a comprehensive solution to centralize documentation processes at Pace® Life Sciences, a U.S.-based contract development and manufacturing organi...
BioTech
20 March, 2026 | Friday | News
Excalipoint Therapeutics Secures 68.7 Million Dollar Seed Financing To Advance Next Generation T Cell Engager Platforms
Funding to advance proprietary T-cell engager platforms and pipeline of highly differentiated T-cell engager therapies targeting solid tumors and autoimmune diseases Financing co-led by multiple top-tier f...
Contract Services
20 March, 2026 | Friday | News
CellCarta And Biofidelity Expand Global Partnership With Exclusive Aspyre Lung Deployment In Clinical Trials
CellCarta and Biofidelity announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings. Building on their existing collaboration announced ...
Consumer Health
10 March, 2026 | Tuesday | News
China Clears IND For Harbour BioMed And Kelun Biotech Bispecific Antibody For Atopic Dermatitis
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Kelun-Biotech (6990.HK) today announced...
White Paper
20 March, 2026 | Friday | Analysis
Taiwan Strengthens Its Position In Asia’s Next Phase Of Bioprocessing Growth
Product Spot Light
11 March, 2026 | Wednesday | News
Waters Corporation Launches ARES G3 Rheometer To Accelerate Materials Research And Testing
Premium Article
15 December, 2025 | Tuesday | Report
APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
Bio Invest
20 March, 2026 | Friday | News
SK Pharmteco Commits 100 Million Dollars To Strengthen Viral Vector Capabilities And Multi Modality CDMO Strategy
Biopharma APAC Infomercial
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
